Why Coeur Mining, Inc. (CDE) Soared On Wednesday
We recently published a list of . In this article, we are going to take a look at where Coeur Mining, Inc. (NYSE:CDE) stands against other best-performing stocks.
Coeur Mining saw its share prices rise by 4.33 percent on Wednesday to finish at $8.43 apiece following the launch of a $75-million share buyback, effective through May 31, 2026.
In a statement, Coeur Mining, Inc. (NYSE:CDE) President and Chief Executive Officer Mitchell Krebs said that the initiative was aimed at boosting shareholder value.
Aerial view of a gold mine, reflecting the company's precious metals mining operations.
Coeur Mining, Inc. (NYSE:CDE) said repurchases under the program may be carried out from time to time through opportunistic open-market purchases or by other means in amounts and at prices that the company deems appropriate.
In recent news, Coeur Mining, Inc. (NYSE:CDE) said it swung to a net income of $33.4 million from a $29.1 million net loss in the same period last year. Revenues jumped by 69 percent to $360.1 million from $213.1 million year-on-year.
For the full year 2025, Coeur Mining, Inc. (NYSE:CDE) expects to produce 95,000 to 105,000 ounces of gold and 5.4 million to 6.5 million ounces of silver. It also targets to spend between $26 million and $32 million, consisting primarily of sustaining capital and underground development.
Overall, CDE ranks 7th on our list of best-performing stocks. While we acknowledge the potential of CDE, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than CDE and that has 10,000x upside potential, check out our report about this cheapest AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.
Disclosure: None. This article is originally published at Insider Monkey.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
an hour ago
- Business Wire
Lazard Opens New UK Headquarters in Historic Manchester Square, W1
LONDON--(BUSINESS WIRE)--Lazard, Inc. (NYSE: LAZ) announced today that its new UK headquarters opened at 20 Manchester Square, housing both the firm's Financial Advisory and Asset Management businesses. The new, larger office reflects Lazard's commitment to London as one of the world's leading financial centres and the firm's continued growth in Europe. 20 Manchester Square will become part of Lazard's European footprint and one of its three main global offices, alongside New York and Paris. As a cornerstone of Lazard's international network, the new UK HQ extends the firm's long-standing presence in London which dates back to 1877. Cyrus Kapadia, Co-Head of European Investment Banking and CEO of UK Financial Advisory, said: "The move to 20 Manchester Square underscores our unwavering commitment to the UK and our deep-rooted heritage in London. We have been successfully growing our European teams and network to further support our clients across Europe and around the globe." Jeremy Taylor, CEO of Lazard UK Asset Management said, '20 Manchester Square is more than just a new office—it's a reflection of our values and vision. We are committed to delivering exceptional performance for our clients. This new UK headquarters embodies our dedication to innovation, collaboration, and thoughtful stewardship as we continue to best serve the needs of our clients.' The new building offers modern office space and has been designed with an emphasis on innovation and sustainable standards of construction, technology and use. The space has renewable energy from solar panels on the roof and a rainwater harvesting system. The building's construction adhered to the UK Green Building Council framework for net-zero carbon emissions and recycled, long-life materials with reduced replaceability have been used across floors, walls and ceiling finishes, with water efficient taps, showers and fixtures in place throughout. 20 Manchester Square is situated next door to the Wallace Collection and Regent's Park, and the area is well known for its cultural landmarks and accessible transport links. Lazard UK is relocating from 50 Stratton Street, after over twenty years. ABOUT LAZARD Founded in 1848, Lazard is the preeminent financial advisory and asset management firm, with operations in North and South America, Europe, the Middle East, Asia, and Australia. Lazard provides advice on mergers and acquisitions, capital markets and capital solutions, restructuring and liability management, geopolitics, and other strategic matters, as well as asset management and investment solutions to institutions, corporations, governments, partnerships, family offices, and high net worth individuals. For more information, please visit and follow Lazard on LinkedIn.
Business Insider
an hour ago
- Business Insider
Bell Potter Reaffirms Their Buy Rating on Trajan Group Holdings Ltd (TRJ)
In a report released today, Martyn Jacobs from Bell Potter maintained a Buy rating on Trajan Group Holdings Ltd (TRJ – Research Report), with a price target of A$1.50. Confident Investing Starts Here: Jacobs covers the Healthcare sector, focusing on stocks such as EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh, Trajan Group Holdings Ltd, and Medical Developments International Limited. According to TipRanks, Jacobs has an average return of -21.3% and a 13.92% success rate on recommended stocks. Trajan Group Holdings Ltd has an analyst consensus of Moderate Buy, with a price target consensus of A$1.53. The company has a one-year high of A$1.31 and a one-year low of A$0.72. Currently, Trajan Group Holdings Ltd has an average volume of 29.48K.
Business Insider
2 hours ago
- Business Insider
Bernstein Keeps Their Hold Rating on Pfizer (PFE)
Bernstein analyst Courtney Breen maintained a Hold rating on Pfizer (PFE – Research Report) yesterday and set a price target of $30.00. Confident Investing Starts Here: Breen covers the Healthcare sector, focusing on stocks such as Eli Lilly & Co, Pfizer, and Moderna. According to TipRanks, Breen has an average return of -0.1% and a 27.78% success rate on recommended stocks. In addition to Bernstein, Pfizer also received a Hold from Berenberg Bank's Kerry Holford in a report issued on May 29. However, on May 30, DBS maintained a Buy rating on Pfizer (NYSE: PFE). The company has a one-year high of $31.54 and a one-year low of $20.92. Currently, Pfizer has an average volume of 53.81M. Based on the recent corporate insider activity of 27 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of PFE in relation to earlier this year. Most recently, in March 2025, JENNIFER B. DAMICO, the SVP & Controller of PFE sold 3,249.00 shares for a total of $84,373.90.
